Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Current Report · Items 5.02, 9.01 · 8-K

Vyome Holdings, Inc.

HINDNASDAQEQUITYCurrent

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On August 27, 2026, the board of directors (the “Board”) of Vyome Holdings, Inc. (the “Company”) appointed Jerry Leonard as the Company’s Chief Financial Officer. In connection with Mr.…

Filed Aug 28, 2026Accepted Aug 28, 2026, 4:31 PM EDTCIK 1427570Accession 0001213900-26-095093
Share

Company context

Vyome is building the world’s premier platform spanning the US-India innovation corridor. Vyome’s immediate focus is on leveraging its clinical-stage assets to transform the lives of patients with immuno-inflammatory conditions. By applying groundbreaking science and its unique positioning, Vyome seeks to deliver lasting value to shareholders in a hyper cost-efficient manner while upholding global standards of quality and safety.

Current securities

Recent company filings

  1. 4 filingSep 3, 2026
  2. Results of Operations and Financial ConditionAug 25, 2026
  3. 10-Q filingAug 12, 2026
  4. Results of Operations and Financial ConditionMay 29, 2026
  5. 10-Q filingMay 12, 2026

Disclosure sections

Items 5.02, 9.01

Select an item to read the extracted section. The as-filed document remains the primary evidence.

Item 5.02Item 5.02 - Departure/Election of Directors
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On August 27, 2026, the board of directors (the “Board”) of Vyome Holdings, Inc. (the “Company”) appointed Jerry Leonard as the Company’s Chief Financial Officer. In connection with Mr. Leonard’s appointment, the Board, upon the recommendation of the compensation committee of the Board, approved a Consulting Agreement (the “CFO Agreement”) with ClearbridgeCFO, LLC, a Georgia limited liability company (“ClearBridge”), and Mr. Leonard, pursuant to which ClearBridge will assign Mr. Leonard to provide services as the Company’s Chief Financial Officer, effective as of September 1, 2026 (the “Effective Date”). In connection with his appointment, as of the Effective Date, Mr. Leonard will serve as the Company’s principal financial officer and principal accounting officer. Pursuant to the CFO Agreement, dated August 27, 2026, the Company will pay ClearBridge a consulting fee of $15,000 per calendar month (the “Consulting Fee”). The CFO Agreement has an initial term commencing on the Effective Date and continuing through the first anniversary of the Effective Date, and will automatically renew for successive 12-month periods unless earlier terminated in accordance with its terms or extended by mutual written agreement of the parties. The CFO Agreement may be terminated by either party: (a) for Cause (as defined in the CFO Agreement), upon 15 days’ prior written notice; (b) without Cause, upon 60 days’ prior written notice; (c) by the Company with immediate effect if Mr. Leonard ceases to be made available by ClearBridge and a replacement acceptable to the Company is not made available within 30 days, in which case the Company will pay ClearBridge the Consulting Fee prorated through the effective date of termination, plus any accrued and unreimbursed expenses; or (d) in connection with an unresolved conflict of interest. Mr. Leonard, age 58, is the founder and Chief Executive Officer of ClearBridgeCFO, an Atlanta-based fractional CFO and financial transformation firm. Since March 2026, Mr. Leonard serves as fractional Chief Financial Officer and Secretary of VSee Health (OTC: VSEE), a telehealth company, pursuant to an assignment through ClearbridgeCFO. Previously, Mr. Leonard served as the Senior Vice President, Chief Financial Officer and Secretary of VSee Health from June 2024 to March 2026. He also served as Chief Financial Officer of iDoc Telehealth Solutions (“iDoc”) and VSee Lab, from March 2021 and June 2022, respectively, to June 2024, when each company became a subsidiary of VSee Health. Prior to his position with iDoc, Mr. Leonard was Vice President of Finance from 2010 to June 2021 within the Asset Management business of Voya Financial, Inc. (NYSE: VOYA). Preceding his role at Voya, he held various finance leadership positions at IBM (NYSE: IBM) and Colgate-Palmolive (NYSE: CL). He started his career in public accounting at Arthur Andersen and PricewaterhouseCoopers. Mr. Leonard is a Certified Public Accountant (CPA). Mr. Leonard received his MBA from Emory University and a BBA in Accounting from Baruch College (C.U.N.Y.) in New York City. There are no arrangements or understandings between Mr. Leonard and any other person pursuant to which Mr. Leonard was selected as the Company’s Chief Financial Officer. There are no family relationships between Mr. Leonard and any director or executive officer of the Company. There are no transactions in which Mr. Leonard has an interest requiring disclosure under Item 404(a) of Regulation S-K. On August 25, 2026, Robert Dickey notified the Company’s board of directors of his intention to voluntary resignation from his position as Interim Chief Financial Officer effective August 31, 2026. Mr. Dickey’s resignation was not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies, or practices. In connection with Mr. Dickey’s resignation, the Company’s consulting agreement with Foresite Advisors, LLC, dated August 26, 2024, will be deemed terminated as of August 31, 2026. The foregoing description of the CFO Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the CFO Agreement, a copy of which is filed as Exhibit 10.1 to this Current Report on Form 8-K.